Bcl-2-IN-21 (compound C1), an iridium-based anticancer agent, effectively targets and inhibits Bcl-2, thereby impeding cancer cell colony formation and promoting increased levels of Bax and caspase 3.
Molecular Weight:
980.96
Formula:
C45H33F6IrN5P
Target:
Bcl-2 Family
* VAT and and shipping costs not included. Errors and price changes excepted